Glucokinase-maturity onset diabetes of the young (GCK-mody)

Clinical trials for Glucokinase-maturity onset diabetes of the young (GCK-mody) explained in plain language.

Never miss a new study

Get alerted when new Glucokinase-maturity onset diabetes of the young (GCK-mody) trials appear

Sign up with your email to follow new studies for Glucokinase-maturity onset diabetes of the young (GCK-mody), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New study tests if cutting insulin boosts heart health in type 1 diabetes

Knowledge-focused Recruiting now

This early-phase study looks at whether reducing high insulin levels (common in type 1 diabetes) with an SGLT2 inhibitor can improve heart and blood sugar health. Researchers will compare people with type 1 diabetes, those with a mild genetic diabetes (GCK-MODY), and healthy volu…

Matched conditions: GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY)

Early phase 1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:06 UTC

Glucokinase-maturity onset diabetes of the young (GCK-mody)

Get alerted when new Glucokinase-maturity onset diabetes of the young (GCK-mody) trials appear

New study tests if cutting insulin boosts heart health in type 1 diabetes